Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2023 Results Conference Call August 2, 2023 4:30 PM ET

Company Participants

Karina Calzadilla - Head, IR

Chad Robins - CEO and Co-founder

Tycho Peterson - CFO

Nitin Sood - Chief Commercial Officer, MRD

Harlan Robins - Chief Scientific Officer and Co-founder

Sharon Benzeno - Chief Commercial Officer, Immune Medicine

Conference Call Participants

Rachel Vatnsdal - JPMorgan Chase

Dan Brennan - TD Cowen

David Westenberg - Piper Sandler

Mark Massaro - BTIG

Elizabeth Webster - Goldman Sachs

Yuko Oku - Morgan Stanley

Dan Leonard - Credit Suisse

Derik de Bruin - Bank of America

Sharon Benzeno - Chief Commercial Officer, Immune Medicine

Operator

Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be question-and-answer session. [Operator Instructions] Pleased be advised that today’s conference is being recorded.

I would now like to hand the conference over to your speaker today, Karina Calzadilla, Head of Investor Relations.

Karina Calzadilla

Thank you, Jacinda, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies second quarter 2023 earnings conference call. Earlier today, we issued a press release reporting Adaptive financial results for the second quarter of 2023. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call and we’ll be referencing to a slide presentation that has been posted to the Investors section in our corporate website.

During the call, management will make projections and other forward-looking statements within the meaning of federal securities laws regarding future events and the future financial performance of the Company. These statements reflect management’s current perspective of the business as of today. Actual results may differ materially from today’s forward-looking statements, depending on a number of factors, which are set forth in our public filings with the SEC and listed in this presentation. In addition, non-GAAP financial measures will be discussed during this call, and a reconciliation from non-GAAP to GAAP metrics can be found in our earnings release.

Joining the call today are Chad Robins, our CEO and Co-founder; and Tycho Peterson, our Chief Financial Officer. Additional members from management will be available for Q&A.

With that, I’ll turn the call over to Chad Robins. Chad?

Chad Robins

Thanks, Karina. Good afternoon, everybody, and thank you for joining us on our second quarter 2023 earnings call.